Ovid Therapeutics Inc.

OVIDNASDAQHealthcare● Active

$2.41

+$0.05(+1.91%)

Market Cap$317182148

P/E Ratio—

52W High$3.105

52W Low$0.272

Avg Volume3.2M

Open$2.39

Beta0.18

Net Income Financials Revenue

Ovid Therapeutics Inc. (OVID) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

OVID · net income · updated Jun 9, 2026

Core profitability metrics

OVID · net income · margin · TTM · CAGR

Net income was −$17.4M for FY2025 (fiscal year ending 2025-12-31), up 34.1% year-over-year. Net profit margin was -240.1%. Based on available data, Ovid Therapeutics Inc. has been profitable since at least 2021.

FY2025 Net Income−$17.4M▲ +34.1% YoY

Trailing 12M (TTM)−$24.2Mtrailing 4 quarters sum

Net Profit Margin-240.1%−$17.4M ÷ $7.3M

YoY Change+34.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · OVID net income history · OVID profit margin

Annual net income data

OVID · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$17.4M▲ +34.1%-240.1%$7.3M

FY2024Loss−$26.4M▲ +49.5%-4670.1%$566,000

FY2023Loss−$52.3M▲ +3.4%-13351.8%$392,000

FY2022Loss−$54.2M▼ 144.1%-3604.7%$1.5M

FY2021★ First Profit$122.8M▲ +251.6%59.0%$208.4M

Net income vs peers (Healthcare)

OVID vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ovid Therapeutics Inc.YOU

OVID

−$17.4M+34.1%-240.1%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ovid Therapeutics Inc. (OVID) reported net income of −$17.4M for FY2025 (fiscal year ending 2025-12-31), up 34.1% year-over-year. The net profit margin was -240.1% — meaning the company kept $-2.40 of every dollar of revenue as profit.

Based on available data, Ovid Therapeutics Inc. has been profitable since at least 2021. Net income reached a peak of $122.8M in FY2021. Data available for 12 fiscal years.

Ovid Therapeutics Inc.'s net profit margin was -240.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Ovid Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from OVID net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

OVID net income · 4 questions

Ovid Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $17.4M for FY2025.

is OVID profitabledoes OVID make a profitOVID profitabilityOVID profitable company

▸ Source: FMP /income-statement · GAAP · Ovid Therapeutics Inc. · Ovid Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026